Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate

European Urology

Volumn 48, Issue 4, 2005, Pages 608-613

  Volkan, Tugcu ^a,d   Ihsan, Tasci Ali ^a   Yilmaz, Ordekci ^b   Emin, Ozbek ^c   Selcuk, Sahin ^a   Koray, Kantay ^b   Bedi, Ozbay ^a  

^a Bakirkoy Women and Children Training and Research Hospital   (Turkey)

^b Nisa Hospital   (Turkey)

^c VAKIF GUREBA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d NONE   (Turkey)

Author keywords

KTP; Laser surgery; Prostate; Prostatic hyperplasia; Vaporization

Indexed keywords

ADULT; AGED; ARTICLE; BALLOON CATHETER; BLADDER CONTRACTION; BLADDER NECK STENOSIS; CATHETERIZATION; DYSURIA; EVALUATION; FEMALE; HEMATURIA; HUMAN; LASER; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POTASSIUM TITANYL PHOSPHATE LASER; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; RESIDUAL URINE; SAFETY; SCORING SYSTEM; URINARY TRACT INFECTION; URINE FLOW RATE;

AGED; AGED, 80 AND OVER; HEMOGLOBINS; HEMOSTASIS, SURGICAL; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; PHOSPHATES; PREOPERATIVE CARE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; TIME FACTORS; TITANIUM; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; URINATION DISORDERS; WATER-ELECTROLYTE BALANCE;

EID: 24644437856     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.07.013     Document Type: Article

References (35)

1. W.M. Garraway, N. Collins, and R.J. Lee High prevalence of benign prostatic hypertrophy in the community Lancet 338 1991 469 471
2. R.J. Glynn, E.W. Campion, and G.R. Bouchard The development of benign prostatic hyperplasia among volunteers in the Normative Ageing Study Am J Epidemiol 121 1 1985 78 90
3. H.A. Guess, H.M. Arrighi, and E.J. Metter Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia Prostate 17 1990 241 246
4. Barry MJ, Beckley S, et al Importance of understanding the epidemiology and natural history of BPH, In: Proceedings of the International Consultation on Benign Prostatic Hyperplasia, WHO 1997; p.25.
5. AUA Practice Guidlines Committee: AUA guidline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170:530-47.
6. D.J. Malenka, N. Roos, and E.S. Fischer Furtherstudy of the increased mortality following transurethral prostatectomy; a chart based analysis J Urol 144 1990 224 228
7. S. Madersbacher, and M. Marberger Is transurethral resection of the prostate stil justified? BJU Int 83 1999 227 237
8. W.K. Mebust, H.L. Holtgrewe, and A.T.K. Cockett Transurethral prostatectomy: Immediate and postoperative complications: Cooperative study of 13 participating instutions evaluating 3885 patients J Urol 141 1989 243 247
9. W. Horninger, H. Unterlechner, and H. Strasser Transurethral prostatectomy: Mortality and morbidity Prostate 28 3 1996 195 200
10. H.A. Doll, N.A. Black, and K. McPherson Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy J Urol 147 1992 1566 1573
11. J. McConnell, M. Barry, and R. Bruskewitz Benign prostatic hyperplasia: Diagnosis and treatment Clin Pract Guide Quick Ref Guide Clin 8 1994 1 17
12. R. Bruskewitz, E. Larsen, and P. Madsen Three year follow-up of urinary symptoms after transurethral resection of the prostate J Urol 136 1986 613 615
13. C.C. Schulman, A.R. Zlotta, and J.S. Rasor Transurethral needle ablation (TUNA): Safety, feasibility and tolerance of a new office procedure for treatment of benign prostatic hyperplasia Eur Urol 24 3 1993 415 423
14. S.A. Kaplan, and A.E. Te A comperative study of transurethral resection of the prostate susing a modified electro-vaporizing loop and transurethral laser vaporization of the prostate J Urol 154 5 1995 1785 1790
15. P. Faul, G. Farin, and O. Reich The "band electrode": First experience with a novel TURP procedure to improve hemostasis Eur Urol 30 3 1996 403 408
16. A.P. Perlmutter, and D.A. Schulsinger The 'wedge' resection device for electrosurgical transurethral prostatectomy J Endourol 12 1998 75 79
17. A.J. Costello, W.G. Bowsher, and D.M. Bolton Laser ablation of the prostate in patients with benign prostatic hypertrophy Br J Urol 69 6 1992 603 608
18. J.N. Kabalin, G. Bite, and S. Doll Neodymium:YAG laser coagulation prostatectomy: 3 years of experience with 227 patients J Urol 155 1 1996 181 185
19. R. Mushter, and A. Hoffstetter Interstitial laser therapy outcomes in benign prostatic hyperplasia J Endourol 9 2 1995 129 135
20. R. Bihrle, R.S. Forster, and N.T. Sanghvi High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: Early United States clinical experiences J Urol 51 5 1994 1271 1275
21. M.L. Blute, K.M. Tomera, and D.K. Hellerstein Transurethral microwave thermotheraphy for management of benign prostatic hyperplasia: Results of the United States Prostatron Cooperative Study J Urol 50 5 1993 1591 1596
22. O. Reich, A. Bachman, and M. Siebels High power (80 W) potassium titanyl phosphate laser vaporization of the prostate in 66 high risk patients J Urol 173 1 2005 158 160
23. N.J. Barber, and G.H. Muir High power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate Curr Opin Urol 14 1 2004 21 25
24. R.S. Kuntzman, R.S. Malek, and D.M. Barrett Potassium titanyl phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines Urology 48 4 1996 575 583
25. R.S. Malek, R.S. Kuntzman, and D.M. Barrett High-power potassium titanyl phosphate laser vaporization prostatectomy J Urol 163 6 2000 1730 1733
26. M.A. Hai, and R.S. Malek Photoselective vaporization of the prostate: initial experience with a new 80 W laser for the treatment of benign prostatic hyperplasia J Endourol 17 2 2003 93 96
27. O. Reich, A. Bachmann, and P. Schneede Experimental comparison of high-power potassium-titanyl-phosphate laser vaporization and transurethral resection of the prostate J Urol 171 6 2004 2502 2504
28. J.S. Sandhu, C. Ng, and B.A. Vanderbrink High-power-potassium-titanyl- phosphate laser vaporization of the prostat efor treatment of benign prostatic hyperplasia in men with large prostates Urology 64 6 2004 1155 1159
29. W.B. Shingleton, P. Farabaugh, and W. May Three-year follow-up laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia Urology 60 2 2002 305 308
30. M.P. Van Iersel, C.M.G. Thomas, and W.P.J. Witjes Clinical implications of the rise and fall of prostate spesific antigen after laser prostatectomy Br J Urol 78 5 1996 742 746
31. N.J. Kabalin Laser prostatectomy performed with a right angle firing neodymium: YAG laser fiber at 40 watts power setting J Urol 150 1993 95 99
32. S.G. Vesey, N.M. Goble, and M.J. Stower The effects of transurethral prostatectomy on serum prostate spesific antigen Br J Urol 62 4 1998 347 351
33. J.E. Oesterling, D.C. Rice, and W.J. Glenski Effects of cystoscopy, prostate biopsy and transurethral resection of prostate on serum prostate spesific antigen concentration Urology 42 3 1993 276 282
34. C. Dincel, M.M. Samli, and C. Guler Plasma kinetic vaporization of the prostate: Clinical evaluation of a new technique J Endourol 18 3 2004 293 298
35. P. Cohen, H.C.B. Graves, and D.M. Peehl Prostate spesific antigen is an insuline-like growth factor binding protein 3 protease found in seminal vesicle J Clin Endocrinol Metab 75 4 1992 1046 1053